Clinical Trials
7 trialsNCT07583953 2026-05-13
An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT07505069 2026-04-01
Exploring the Clinical Value of RT01-89Zr PET Imaging in Solid Tumors
Nanolattix Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Recruiting
NCT04237649 2025-05-18
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Novartis
Phase EARLY_PHASE1 Terminated
NCT06951425 2025-05-13
An Exploratory Clinical Study of the Efficiency and Safety of TH027 in the Treatment of Relapsed/Refractory Solid Tumors
Shanghai Tongji Hospital, Tongji University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT05648994 2022-12-13
TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT02157831 2018-08-17
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed
NCT00583063 2013-06-12
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
University of Chicago
Phase EARLY_PHASE1 Completed